PharmaShots | Incisive News in 3 Shots

Subscribe Now

Reduced

Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA VOYAGE Study in Children with Asthma

Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA VOYAGE Study in Children with Asthma

October 13, 2020

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthri...

August 6, 2020

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fra...

July 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us